A dual-target car-t therapy is showing promise in treating aggressive brain tumors. The therapy, which has been used in clinical trials, has been reported to slow the growth of brain cancer and show dramatic regression of glioblastoma in some cases. However, it is unclear if this therapy is specifically for adult or pediatric brain tumors, or both, as some reports mention its potential for treating deadly brain cancer in general, while others specify its use for pediatric brain tumors or specific types of glioblastoma.